Tocilizumab Injectable Product

DRUG2 trials

Sponsors

Rigshospitalet, Denmark, Tang-Du Hospital

Conditions

Appetitive BehaviorInterleukin-6 InhibitionMyasthenia Gravis, GeneralizedPhysical Stress

Phase 2

Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis

RecruitingNCT05067348

Tang-Du HospitalMyasthenia Gravis, Generalized

Start: 2022-07-21End: 2026-03-30Target: 64Updated: 2025-05-01

Unknown Phase

Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

CompletedNCT04616235

Rigshospitalet, DenmarkAppetitive Behavior, Interleukin-6 Inhibition, Physical Stress

Start: 2021-03-15End: 2021-10-04Updated: 2022-08-22